Background illustration for clinical trials search

Paid Clinical Trials Dayton

Discover 1,190 paid clinical trials in Dayton, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria

for
Urticaria Chronic
Location: Cincinnati OH, Glenview IL
Sponsor: ARS Pharmaceuticals, Inc.

Sex: All

Age: 18 - 65

Code: NCT06927999

Phase 2, Recruiting

Non-randomized Observational Study to Evaluate ReX® in the Management of Solid Oral Medication.

for
Any Solid Oral Medication
Location: Cincinnati OH
Sponsor: Dosentrx Ltd.

Sex: All

Age: 18+

Code: NCT06335758

Recruiting

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

for
Large B-cell Lymphoma
Location: Cincinnati OH, Indianapolis IN, Fort Wayne IN,
Sponsor: Allogene Therapeutics

Sex: All

Age: 18+

Code: NCT06500273

Phase 2, Recruiting

A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia

for
Idiopathic Hypersomnia, Narcolepsy Type 1, Narcolepsy Type 2
Location: Cincinnati OH, Southfield MI, Winston-Salem NC,
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT07646678

Phase 2, Phase 3, Recruiting

Evaluate the Safety and Pharmacokinetic Profile of ETR028 and ETR029 in Healthy Adult Subjects

for
Acute Pain
Location: Cincinnati OH
Sponsor: Elysium Therapeutics, Inc.

Sex: All

Age: 18 - 55

Code: NCT05572190

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Single- and Multiple-Ascending Dose Study of SRK-439 in Healthy Adults

for
Healthy
Location: Cincinnati OH
Sponsor: Scholar Rock, Inc.

Sex: All

Age: 18 - 55

Code: NCT07444294

Phase 1, Recruiting

An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumors
Location: Cincinnati OH, Detroit MI, Pittsburgh PA, Chicago IL,
Sponsor: Teva Branded Pharmaceutical Products R&D LLC

Sex: All

Age: 18+

Code: NCT06480552

Phase 1, Recruiting

Safety and Tolerability of FB-001 in Healthy Adult Volunteers and Adult Subjects With Enteric Hyperoxaluria

for
Healthy, Enteric Hyperoxaluria
Location: Cincinnati OH
Sponsor: Federation Bio Inc.

Sex: All

Age: 18 - 70+

Code: NCT05650112

Phase 1, Recruiting

A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants

for
Obesity, Obese
Location: Cincinnati OH
Sponsor: Hanmi Pharmaceutical Company Limited

Sex: All

Age: 18 - 65

Code: NCT07219589

Phase 1, Recruiting

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

for
Focal Segmental Glomerulosclerosis
Location: Cincinnati OH, Columbus OH, Brunswick OH, Detroit MI,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 12+

Code: NCT07220083

Phase 3, Recruiting

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Cincinnati OH, Columbus OH, Gahanna OH, Greenwood IN,
Sponsor: CG Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06567743

Phase 2, Recruiting

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

for
Urinary Bladder Neoplasms,
Location: Cincinnati OH, Chicago Ridge IL, Columbia MO,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06833073

Phase 2, Recruiting

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

for
Prostate Cancer
Location: Cincinnati OH, Gahanna OH, Detroit MI, Morgantown WV,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT06855277

Phase 3, Recruiting

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Location: Cincinnati OH, Gahanna OH, Carmel IN, Jeffersonville IN,
Sponsor: Dendreon

Sex: Male

Age: 18+

Code: NCT06134232

Phase 2, Recruiting

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

for
Metastatic Castration Sensitive Prostate Cancer (mCSPC),
Location: Cincinnati OH, Avon OH, Cleveland OH, Orange OH,
Sponsor: Pfizer

Sex: Male

Age: 18+

Code: NCT07028853

Phase 3, Recruiting

A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia

for
Dystonia
Location: Cincinnati OH, Farmington Hills MI, East Lansing MI,
Sponsor: Vima Therapeutics

Sex: All

Age: 18 - 70

Code: NCT07304089

Phase 2, Recruiting

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

for
Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Location: Cincinnati OH, Dublin OH, Canton OH, Lansing MI,
Sponsor: Alkermes, Inc.

Sex: All

Age: 18 - 70

Code: NCT06767683

Phase 2, Phase 3, Recruiting

Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old

for
Migraine Disorders
Location: Cincinnati OH, Huntington WV, Tampa FL, La Jolla CA,
Sponsor: Upsher-Smith Laboratories

Sex: All

Age: 6 - 11

Code: NCT04748601

Recruiting

The Aim of This Study is to Determine if Oocyte Sorting for Group Culture Using an Artificial Intelligence Image Analysis Tool (MagentaTM) Increases the Usable Blastocyst Yield and Subsequent Pregnancy in Patients Undergoing IVF

for
Infertility Primary
Location: Cincinnati OH, Nashville TN, Las Vegas NV
Sponsor: Ovation Fertility

Sex: All

Age: 0+

Code: NCT06521372

Recruiting

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

for
Asthma
Location: Cincinnati OH, Cleveland OH, Owensboro KY, Normal IL,
Sponsor: GlaxoSmithKline

Sex: All

Age: 12 - 17

Code: NCT05757102

Phase 3, Recruiting